168 related articles for article (PubMed ID: 38256152)
21. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
22. Systemic modulation of stress and immune parameters in patients treated for prostate adenocarcinoma by intensity-modulated radiation therapy or stereotactic ablative body radiotherapy.
Frey B; Mika J; Jelonek K; Cruz-Garcia L; Roelants C; Testard I; Cherradi N; Lumniczky K; Polozov S; Napieralska A; Widlak P; Gaipl US; Badie C; Polanska J; Candéias SM
Strahlenther Onkol; 2020 Nov; 196(11):1018-1033. PubMed ID: 32519025
[TBL] [Abstract][Full Text] [Related]
23. REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer.
Seibold P; Webb A; Aguado-Barrera ME; Azria D; Bourgier C; Brengues M; Briers E; Bultijnck R; Calvo-Crespo P; Carballo A; Choudhury A; Cicchetti A; Claßen J; Delmastro E; Dunning AM; Elliott RM; Fachal L; Farcy-Jacquet MP; Gabriele P; Garibaldi E; Gómez-Caamaño A; Gutiérrez-Enríquez S; Higginson DS; Johnson K; Lobato-Busto R; Mollà M; Müller A; Payne D; Peleteiro P; Post G; Rancati T; Rattay T; Reyes V; Rosenstein BS; De Ruysscher D; De Santis MC; Schäfer J; Schnabel T; Sperk E; Symonds RP; Stobart H; Taboada-Valladares B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Ward T; Weißenberger C; West CML; Chang-Claude J;
Radiother Oncol; 2019 Sep; 138():59-67. PubMed ID: 31146072
[TBL] [Abstract][Full Text] [Related]
24. Defining TNF-α- and LPS-induced gene signatures in monocytes to unravel the complexity of peripheral blood transcriptomes in health and disease.
Smiljanovic B; Grün JR; Steinbrich-Zöllner M; Stuhlmüller B; Häupl T; Burmester GR; Radbruch A; Grützkau A; Baumgrass R
J Mol Med (Berl); 2010 Oct; 88(10):1065-79. PubMed ID: 20640394
[TBL] [Abstract][Full Text] [Related]
25. Comparison of mouse urinary metabolic profiles after exposure to the inflammatory stressors γ radiation and lipopolysaccharide.
Laiakis EC; Hyduke DR; Fornace AJ
Radiat Res; 2012 Feb; 177(2):187-99. PubMed ID: 22128784
[TBL] [Abstract][Full Text] [Related]
26. Comparison between radiation-induced cell cycle delay in lymphocytes and radiotherapy response in head and neck cancer.
Tell R; Heiden T; Granath F; Borg AL; Skog S; Lewensohn R
Br J Cancer; 1998 Feb; 77(4):643-9. PubMed ID: 9484824
[TBL] [Abstract][Full Text] [Related]
27. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study.
Lalonde E; Ishkanian AS; Sykes J; Fraser M; Ross-Adams H; Erho N; Dunning MJ; Halim S; Lamb AD; Moon NC; Zafarana G; Warren AY; Meng X; Thoms J; Grzadkowski MR; Berlin A; Have CL; Ramnarine VR; Yao CQ; Malloff CA; Lam LL; Xie H; Harding NJ; Mak DYF; Chu KC; Chong LC; Sendorek DH; P'ng C; Collins CC; Squire JA; Jurisica I; Cooper C; Eeles R; Pintilie M; Dal Pra A; Davicioni E; Lam WL; Milosevic M; Neal DE; van der Kwast T; Boutros PC; Bristow RG
Lancet Oncol; 2014 Dec; 15(13):1521-1532. PubMed ID: 25456371
[TBL] [Abstract][Full Text] [Related]
28. Defining molecular signature of pro-immunogenic radiotherapy targets in human prostate cancer cells.
Aryankalayil MJ; Makinde AY; Gameiro SR; Hodge JW; Rivera-Solis PP; Palayoor ST; Ahmed MM; Coleman CN
Radiat Res; 2014 Aug; 182(2):139-48. PubMed ID: 25003313
[TBL] [Abstract][Full Text] [Related]
29. The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial.
Pollack A; Karrison TG; Balogh AG; Gomella LG; Low DA; Bruner DW; Wefel JS; Martin AG; Michalski JM; Angyalfi SJ; Lukka H; Faria SL; Rodrigues GB; Beauchemin MC; Lee RJ; Seaward SA; Allen AM; Monitto DC; Seiferheld W; Sartor O; Feng F; Sandler HM
Lancet; 2022 May; 399(10338):1886-1901. PubMed ID: 35569466
[TBL] [Abstract][Full Text] [Related]
30. Reduction in radiation-induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer.
Razzaghdoust A; Mozdarani H; Mofid B; Aghamiri SM; Heidari AH
Prostate; 2014 Jan; 74(1):41-7. PubMed ID: 24019126
[TBL] [Abstract][Full Text] [Related]
31. High-throughput meta-analysis and validation of differentially expressed genes as potential biomarkers of ionizing radiation-response.
Biolatti V; Negrin L; Bellora N; Ibañez IL
Radiother Oncol; 2021 Jan; 154():21-28. PubMed ID: 32931891
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal radiosensitivity analyzed by FISH in lymphocytes of prostate cancer patients and healthy donors.
Schmitz S; Brzozowska K; Pinkawa M; Eble M; Kriehuber R
Radiat Res; 2013 Nov; 180(5):465-73. PubMed ID: 24083681
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Saliva Gene Expression during Head and Neck Cancer Radiotherapy: A Pilot Study.
Lacombe J; Brooks C; Hu C; Menashi E; Korn R; Yang F; Zenhausern F
Radiat Res; 2017 Jul; 188(1):75-81. PubMed ID: 28504589
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cytokine expression and circulating immune cell subsets as potential parameters of acute radiation toxicity in prostate cancer patients.
Stanojković TP; Matić IZ; Petrović N; Stanković V; Kopčalić K; Besu I; Đorđić Crnogorac M; Mališić E; Mirjačić-Martinović K; Vuletić A; Bukumirić Z; Žižak Ž; Veldwijk M; Herskind C; Nikitović M
Sci Rep; 2020 Nov; 10(1):19002. PubMed ID: 33149212
[TBL] [Abstract][Full Text] [Related]
35. Time, dose and ataxia telangiectasia mutated (ATM) status dependency of coding and noncoding RNA expression after ionizing radiation exposure.
Kabacik S; Manning G; Raffy C; Bouffler S; Badie C
Radiat Res; 2015 Mar; 183(3):325-37. PubMed ID: 25738893
[TBL] [Abstract][Full Text] [Related]
36. Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy.
Yang FE; Vaida F; Ignacio L; Houghton A; Nauityal J; Halpern H; Sutton H; Vijayakumar S
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):617-17. PubMed ID: 7558950
[TBL] [Abstract][Full Text] [Related]
37. Effects of lipopolysaccharide exposure in primary bovine ruminal epithelial cells.
Kent-Dennis C; Aschenbach JR; Griebel PJ; Penner GB
J Dairy Sci; 2020 Oct; 103(10):9587-9603. PubMed ID: 32747102
[TBL] [Abstract][Full Text] [Related]
38. Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo.
Morel KL; Ormsby RJ; Bezak E; Sweeney CJ; Sykes PJ
Radiat Res; 2017 May; 187(5):501-512. PubMed ID: 28398879
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous and radiation-induced chromosomal instability and persistence of chromosome aberrations after radiotherapy in lymphocytes from prostate cancer patients.
Hille A; Hofman-Hüther H; Kühnle E; Wilken B; Rave-Fränk M; Schmidberger H; Virsik P
Radiat Environ Biophys; 2010 Mar; 49(1):27-37. PubMed ID: 19760427
[TBL] [Abstract][Full Text] [Related]
40. Development of gene expression signatures for practical radiation biodosimetry.
Paul S; Amundson SA
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1236-1244. PubMed ID: 18572087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
